Toward a New Generation in Humane Therapeutics.


Side Effects are Unacceptable

Through a unique cancer treatment approach, Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell self destruction.  

News > 

Targeting Genomic Instability in Oncology and Autoimmune Disorders

By turning cancer's inherent weakness of genomic instability upon itself, Cyteir Therapeutics' treatment causes the malignant cells to ultimately self destruct. All while leaving the healthy cells unharmed.

Focusing on just one specific source of that genomic instability has unlocked startling capabilities for Cyteir Therapeutics.  

About >

Developing New concepts for cancer therapies and autoimmune disease treatments 

The application of this approach has all ready been validated with clear empirical data.  Results are a successfully targeted treatment capability that, until now, has been unattainable in the oncology field.

Contact >